Format

Send to

Choose Destination
J Back Musculoskelet Rehabil. 2018 Feb 6;31(1):57-64. doi: 10.3233/BMR-169662.

Effectiveness of myofascial trigger point therapy in chronic back pain patients is considerably increased when combined with a new, integrated, low-frequency shock wave vibrotherapy (Cellconnect Impulse): A two-armed, measurement repeated, randomized, controlled pragmatic trial.

Abstract

BACKGROUND:

The prevalence of chronic back pain poses major challenges for all health care systems and patients worldwide. Myofascial trigger therapy (MT), although a very popular standard non-pharmaceutical form of treatment, only shows small to medium effectiveness.

OBJECTIVE:

To test a new vibrotreatment (Cellconnect Impulse) transmitting low-frequency, vertical shock waves in a routine clinical practice.

METHODS:

Eligible patients were adults seeking physiotherapeutic treatment. They were randomly allocated to either six treatments of MT or to six treatments of combined MT and vibrotreatment. Outcome parameters were pain intensity, pain days, pain duration, and quality of life.

RESULTS:

The pain relieving effects of the combined treatment were very large (d= 1.6). It clearly outperformed MT and considerably improved patients' health related quality of life.

CONCLUSIONS:

Combining MT with Cellconnect Impulse enhances the physiotherapeutic effectiveness of treating chronic back pain.

KEYWORDS:

Cellconnect Impulse; chronic back pain; myofascial trigger point therapy; quality of life; vibrotherapy

PMID:
28826166
DOI:
10.3233/BMR-169662
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center